Literature DB >> 24434580

PIP-box-mediated degradation prohibits re-accumulation of Cdc6 during S phase.

Linda Clijsters1, Rob Wolthuis.   

Abstract

Cdc6 and Cdt1 initiate DNA replication licensing when cells exit mitosis. In cycling cells, Cdc6 is efficiently degraded from anaphase onwards as a result of APC/C-Cdh1 activity. When APC/C-Cdh1 is switched off again, at the end of G1 phase, Cdc6 could thus re-accumulate, risking the re-licensing of DNA as long as Cdt1 is present. Here, we carefully investigated the dynamics of Cdt1 and Cdc6 in cycling cells. We reveal a novel APC/C-Cdh1-independent degradation pathway that prevents nuclear Cdc6 re-accumulation at the G1-S transition and during S phase. Similar to Cdt1, nuclear clearance of Cdc6 depends on an N-terminal PIP-box and the Cdt2-containing CRL4 complex. When cells reach G2 phase, Cdc6 rapidly re-accumulates but, at this time, Cdt1 is mostly absent and expression of Cdc6 is limited to the cytoplasm. We propose that Cdk1 contributes to the nuclear export of Cdc6 at the S-to-G2 transition. In summary, our results show that different control mechanisms of Cdc6 restrain erroneous licensing of DNA replication during G1, S and G2 phase.

Entities:  

Keywords:  CRL4–Cdt2; Cdc6; Cdt1; Cell cycle; PCNA; PIP-box

Mesh:

Substances:

Year:  2014        PMID: 24434580     DOI: 10.1242/jcs.145862

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  20 in total

1.  Feedback regulation between atypical E2Fs and APC/CCdh1 coordinates cell cycle progression.

Authors:  Michiel Boekhout; Ruixue Yuan; Annelotte P Wondergem; Hendrika A Segeren; Elsbeth A van Liere; Nesibu Awol; Imke Jansen; Rob M F Wolthuis; Alain de Bruin; Bart Westendorp
Journal:  EMBO Rep       Date:  2016-02-05       Impact factor: 8.807

2.  14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation.

Authors:  Ashraf Dar; David Wu; Nicholas Lee; Etsuko Shibata; Anindya Dutta
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

Review 3.  Forging Ahead through Darkness: PCNA, Still the Principal Conductor at the Replication Fork.

Authors:  Katherine N Choe; George-Lucian Moldovan
Journal:  Mol Cell       Date:  2017-02-02       Impact factor: 17.970

4.  Dynamic loading and redistribution of the Mcm2-7 helicase complex through the cell cycle.

Authors:  Sara K Powell; Heather K MacAlpine; Joseph A Prinz; Yulong Li; Jason A Belsky; David M MacAlpine
Journal:  EMBO J       Date:  2015-01-02       Impact factor: 11.598

5.  The DNA replication protein Cdc6 inhibits the microtubule-organizing activity of the centrosome.

Authors:  Inyoung Lee; Gwang Su Kim; Jun Sung Bae; Jaeyoun Kim; Kunsoo Rhee; Deog Su Hwang
Journal:  J Biol Chem       Date:  2017-08-21       Impact factor: 5.157

Review 6.  Regulation of Mammalian DNA Replication via the Ubiquitin-Proteasome System.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Role of Cdc6 in re-replication in cells expressing human papillomavirus E7 oncogene.

Authors:  Xueli Fan; Yunying Zhou; Jason J Chen
Journal:  Carcinogenesis       Date:  2016-05-06       Impact factor: 4.944

8.  Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs.

Authors:  Linda Clijsters; Claire Hoencamp; Jorg J A Calis; Antonio Marzio; Shanna M Handgraaf; Maria C Cuitino; Brad R Rosenberg; Gustavo Leone; Michele Pagano
Journal:  Mol Cell       Date:  2019-05-23       Impact factor: 17.970

9.  Multiple, short protein binding motifs in ORC1 and CDC6 control the initiation of DNA replication.

Authors:  Manzar Hossain; Kuhulika Bhalla; Bruce Stillman
Journal:  Mol Cell       Date:  2021-03-23       Impact factor: 17.970

Review 10.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.